Posted September 12, 2019
Hidalgo M, Plaza C, Musteanul M, lllei P, Brachmanna C B, Heisea C, Piercea D, Lopez-Casasr PP, Menendezl C, Taberneros J, Romano A, Weia X, Lopez-Rios F, and Von Hoff DD. SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel Plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase lll MPACT Trial. Clin Cancer Res. 2015 Nov 1;21(21):4811-8.